EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection

Clara Bredow, Fabien Thery, Eva Katrin Wirth, Sarah Ochs, Meike Kespohl, Gunnar Kleinau, Nicolas Kelm, Niclas Gimber, Jan Schmoranzer, Martin Voss, Karin Klingel, Joachim Spranger und 11 weitere

Cardiovascular Research · 07.05.2024 · 120 (6) · 644-657

DOI: 10.1093/cvr/cvae026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 03.02.2024. Verfasst von Clara Bredow und 22 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Cha…. Hauptthemen laut MEDLINE: Coxsackievirus Infections, Cytokines, Energy Metabolism, Glycolysis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Foundation for Experimental Biomedicine Zurich, Switzerland, German Research Foundation, International Max Planck Research School for Infectious Diseases and Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Virus infection triggers inflammation and, may impose nutrient shortage to the heart. Supported by type I interferon (IFN) signalling, cardiomyocytes counteract infection by various effector processes, with the IFN-stimulated gene of 15 kDa (ISG15) system being intensively regulated and protein modification with ISG15 protecting mice Coxsackievirus B3 (CVB3) infection. The underlying molecular aspects how the ISG15 system affects the functional properties of respective protein substrates in the heart are unknown. Methods and results Based on the protective properties due to protein ISGylation, we set out a study investigating CVB3-infected mice in depth and found cardiac atrophy with lower cardiac output in ISG15−/− mice. By mass spectrometry, we identified the protein targets of the ISG15 conjugation machinery in heart tissue and explored how ISGylation affects their function. The cardiac ISGylome showed a strong enrichment of ISGylation substrates within glycolytic metabolic processes. Two control enzymes of the glycolytic pathway, hexokinase 2 (HK2) and phosphofructokinase muscle form (PFK1), were identified as bona fide ISGylation targets during infection. In an integrative approach complemented with enzymatic functional testing and structural modelling, we demonstrate that protein ISGylation obstructs the activity of HK2 and PFK1. Seahorse-based investigation of glycolysis in cardiomyocytes revealed that, by conjugating proteins, the ISG15 system prevents the infection-/IFN-induced up-regulation of glycolysis. We complemented our analysis with proteomics-based advanced computational modelling of cardiac energy metabolism. Our calculations revealed an ISG15-dependent preservation of the metabolic capacity in cardiac tissue during CVB3 infection. Functional profiling of mitochondrial respiration in cardiomyocytes and mouse heart tissue by Seahorse technology showed an enhanced oxidative activity in cells with a competent ISG15 system.

Conclusion

Our study demonstrates that ISG15 controls critical nodes in cardiac metabolism. ISG15 reduces the glucose demand, supports higher ATP production capacity in the heart, despite nutrient shortage in infection, and counteracts cardiac atrophy and dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coxsackievirus InfectionsCytokinesEnergy MetabolismGlycolysisMitochondria, HeartMyocytes, CardiacUbiquitinsAnimalsHumansMaleDisease Models, AnimalEnterovirus B, HumanHost-Pathogen InteractionsMice, Inbred C57BLMice, KnockoutProtein Processing, Post-TranslationalSignal Transduction

Stichwörter der Autor:innen

GlycolysisISG15ISGylationMetabolismMitochondrial functionVirus infection

Substanzen

CytokinesG1p2 protein, mouseUbiquitins

Autor:innen und Institutionen

  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany.
  • Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • VIB-UGent Center for Medical Biotechnology, Ghent, Belgium.
  • Deutsches Zentrum für Herz-Kreislauf-Forschung, partner site Berlin, Berlin, Germany.
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Endocrinology, Diabetes and Nutrition, Berlin, Germany.
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Physics and Biophysics, Group Protein X-ray Crystallography and Signal Transduc…

ORCID-Profile: Markus Ralser, Nikolaus Berndt, Antje Beling

Förderung

  • Foundation for Experimental Biomedicine Zurich, Switzerland
  • German Research Foundation
  • International Max Planck Research School for Infectious Diseases and Immunology
  • Advanced Medical Bioimaging Core Facility
  • Charité -Universitätsmedizin
  • Research Foundation Flanders
  • Bundesministerium für Bildung und Forschung
  • German Federal Ministry of Education and Research

Zitieren

APA

Bredow, C., Thery, F., Wirth, E. K., Ochs, S., Kespohl, M., Kleinau, G., Kelm, N., Gimber, N., Schmoranzer, J., Voss, M., Klingel, K., Spranger, J., Renko, K., Ralser, M., Mülleder, M., Heuser, A., Knobeloch, K. P., Scheerer, P., Kirwan, J., …, & Beling, A. (2024). ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection. Cardiovascular Research, 120(6), 644-657. https://doi.org/10.1093/cvr/cvae026

Vancouver

Bredow C, Thery F, Wirth EK, Ochs S, Kespohl M, Kleinau G, et al. ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection. Cardiovascular Research. 2024;120(6):644-657. doi:10.1093/cvr/cvae026

BibTeX
@article{Bredow2024,
  author = {Bredow, Clara and Thery, Fabien and Wirth, Eva Katrin and Ochs, Sarah and Kespohl, Meike and Kleinau, Gunnar and Kelm, Nicolas and Gimber, Niclas and Schmoranzer, Jan and Voss, Martin and Klingel, Karin and Spranger, Joachim and Renko, Kostja and Ralser, Markus and Mülleder, Michael and Heuser, Arnd and Knobeloch, Klaus-Peter and Scheerer, Patrick and Kirwan, Jennifer and Brüning, Ulrike and Berndt, Nikolaus and Impens, Francis and Beling, Antje},
  title = {ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {6},
  pages = {644--657},
  doi = {10.1093/cvr/cvae026}
}
Kostenlos starten →